GYRE – gyre therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update
Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis
Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) market cap dropped US$51m last week; Public companies bore the brunt [Yahoo! Finance]
Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference
Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
Form S-3 GYRE THERAPEUTICS, INC.
Form 10-Q GYRE THERAPEUTICS, INC. For: Sep 30
Form 8-K GYRE THERAPEUTICS, INC. For: Nov 13
Form SC 13D GYRE THERAPEUTICS, INC. Filed by: Ma Songjiang
Form SC 13D GYRE THERAPEUTICS, INC. Filed by: Luo Ying
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.